Patent ID: 9540372
Date: 2017-01-10
CPC Classifications: A61K,A61P,C07D

Claim:
1. A method of inhibiting the progress of, reducing the rate of progress of, alleviating a symptom of, or ameliorating cancer comprising administering to a subject in need of treatment a therapeutically-effective amount of a compound of the following formula, or a pharmaceutically acceptable salt thereof: wherein: —R —R and wherein the cancer is: thyroid cancer; melanoma (including malignant melanoma); lung cancer (including non-small cell lung cancer and small cell lung cancer); colorectal cancer; pancreatic cancer; sarcoma; gastrointestinal cancer; ovarian cancer; lymphoma; leukemia; skin cancer; testicular cancer; prostate cancer; a carcinoma of the cervix; bladder cancer; breast cancer; liver cancer; kidney cancer; stomach cancer; endometrial cancer; seminoma; a hematopoietic tumor of myeloid lineage; myelodisplastic syndrome; a carcinoma of the oesophagus; brain cancer; glioma; bone cancer; or squamous cancer.